(Q45874806)

17 December 2017

title

Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A. (English)

1 reference

17 December 2017

main subject

hemophilia

0 references

Coagulation factor VIII

0 references

hemophilia A

0 references

author name string

Madoiwa S

1

1 reference

17 December 2017

Yamauchi T

2

1 reference

17 December 2017

Hakamata Y

3

1 reference

17 December 2017

Kobayashi E

4

1 reference

17 December 2017

Arai M

5

1 reference

17 December 2017

Sugo T

6

1 reference

17 December 2017

Mimuro J

7

1 reference

17 December 2017

Sakata Y

8

1 reference

17 December 2017

publication date

1 May 2004

1 reference

17 December 2017

Journal of Thrombosis and Haemostasis

published in

1 reference

17 December 2017

volume

2

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

page(s)

754-762

1 reference

17 December 2017

Incidence of inhibitors in haemophilia A patients--a review of recent studies of recombinant and plasma-derived factor VIII concentrates

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

Neonatal exposure to a self-peptide-immunoglobulin chimera circumvents the use of adjuvant and confers resistance to autoimmune disease by a novel mechanism involving interleukin 4 lymph node deviation and interferon gamma-mediated splenic anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

Neonatal exposure to antigen induces a defective CD40 ligand expression that undermines both IL-12 production by APC and IL-2 receptor up-regulation on splenic T cells and perpetuates IFN-gamma-dependent T cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

Cellular mechanisms of immunologic tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

Role of interleukin 12 and costimulators in T cell anergy in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

Experience of prophylaxis treatment in children with severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

Development of a factor VIII inhibitor in a newborn haemophiliac

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7933.2004.00671.X

10.1111/J.1538-7933.2004.00671.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017